Rodale.com, November 2014. Many new cancer treatments cost $10,000 each month or more, and yet three out of four are not proven to extend life, according to a recent study.
Read More »We’re In The News
As a respected nonprofit health research center, our views are often quoted in the media, including newspapers, magazines, TV, radio, and websites. We also write articles and blogs for a number of different and highly respected newspapers, magazines, and popular websites, and we are published in prestigious medical journals and health policy publications. We frequently express our policy views in letters to government officials and public comments to federal agencies and we sometimes release statements or press releases on newsworthy issues.
Please e-mail info@center4research.org or call 202-223-4000 with your inquiries. We can assist you with scheduling interviews with the NCHR President, Dr. Diana Zuckerman, and other experts on our staff.
Essure Birth Control Maker, Conceptus, Cited for Malfunctioning, Not Reporting Complaints
WXYZ Detroit, November 5, 2014. The 7 Investigators obtained records from the Food and Drug Administration (FDA) showing that the original manufacturer of a permanent birth control device, Essure, knew patients were being harmed by the device more than a decade ago.
Read More »Pfizer Loses a Bet On Removing Serious Warnings From Its Chantix Pill
The Wall Street Journal, October 17, 2014. In a setback for Pfizer, an FDA advisory panel yesterday voted overwhelmingly to maintain the most serious warnings on its Chantix smoking cessation pill.
Read More »Is Early Stage Medical Device Development Going Overseas?
Wolters Kluwer Law & Health Blog, October 15, 2014. Even though the FDA has recently proposed a new program to provide earlier market access to high-risk medical devices, FDA Commissioner Margaret Hamburg nevertheless came under fire for the agency being too slow to approve medical devices at the annual conference of the Advanced Medical Technology Association (AdvaMed) in Chicago.
Read More »Antibiotic Resistance: Will Policymakers Resist Effective Strategies?
AAAS, October 14, 2014. One of the most pressing scientific issues facing Congress today is the risk that antibiotic resistance presents to human health. Unfortunately, there is an enormous gap between what the science tells us is needed and the Congressional approach.
Read More »